">

Nippon India Pharma Fund-Growth Plan-Growth Option

(Erstwhile Reliance Pharma Fund-Growth Plan-Growth Option)

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 01-06-2004
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 1.95% As on (31-05-2021)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 5,237.92 Cr As on (31-05-2021)
Turn over: 55.00
NAV as on 23-06-2021

295.2639

-0.98 (-0.333%)

CAGR Since Inception

21.95%

S&P BSE Healthcare TRI 13.96%

PERFORMANCE of Nippon India Pharma Fund-Growth Plan-Growth Option

Scheme Performance (%) Data as on - 23-06-2021

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Nippon India Pharma Fund-Growth Plan-Growth Option 51.25 26.57 17.89 18.03 21.95
S&P BSE Healthcare TRI 47.92 16.41 8.72 14.37 13.96
Equity: Sectoral-Pharma and Healthcare 47.28 24.87 13.69 16.76 24.32

Yearly Performance (%)

Fund Managers

Sailesh Raj Bhan

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

RETURNS CALCULATOR for Nippon India Pharma Fund-Growth Plan-Growth Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of Nippon India Pharma Fund-Growth Plan-Growth Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Nippon India Pharma Fund-Growth Plan-Growth Option 15.77 -0.02 1.92 0.84 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of Nippon India Pharma Fund-Growth Plan-Growth Option

Period
Data as on - 23-06-2021
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 51.25 45.67 26.57 17.89 18.03
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 52.85 48.85 0.0 0.0 0.0
Mirae Asset Healthcare Fund -Regular Growth 05-07-2018 49.92 48.01 0.0 0.0 0.0
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 14-07-1999 49.68 44.71 24.41 11.05 17.44
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 49.18 45.89 0.0 0.0 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 47.37 43.25 23.96 12.96 14.81
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 44.74 40.38 24.53 12.85 0.0
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 41.78 0.0 0.0 0.0 0.0
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 38.73 38.32 0.0 0.0 0.0

PORTFOLIO ANALYSIS of Nippon India Pharma Fund-Growth Plan-Growth Option

Asset Allocation (%)